
Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting
Hematologic Oncology Update
00:00
Is There a Sick Inhibitor in CLL?
Sick inhibitors do sick as associated with FLIT-3 and ZAP-70. It actually has rheumatological indications as well. So yeah, so I think it's pleotropicly active. Now we're going to look at some long term follow up or the of the mentalist trial in patients with a ring sitter blast low risk AML. The primary endpoint was met, whereas the loose batter step had a significant decrease in their eight week transfusion independent rate.
Transcript
Play full episode